Changes in the quantitative characteristics of the Ukrainian market of tear replacement products for dry eye disease over 2016-2019

• Main Authors: V. M. Sakovych (Author), Yu. O. Tomashevska (Author), O. V. Makarenko (Author), O. V. Kryvoviaz (Author), M. S. Garnyk (Author)
• Format: Book
• Published: Ukrainian Society of Ophthalmologists, 2022-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.
• Notes: http://doi.org/10.31288/oftalmolzh202215862; 2412-8740
• Keywords: tear replacement products; dry eye syndrome; retail sales; price niches; Internal medicine; RC31-1245
• Source: Journal of Ophthalmology, Iss 1, Pp 58-62 (2022)

Background: Management of dry eye syndrome (DES) is a current medical, pharmaceutical and social issue both globally and in Ukraine. Purpose: To assess changes in quantitative characteristics of the Ukrainian market of tear replacement products (TRPs) for dry eye disease over 2016-2019. Material and Methods: Data from the national pharmacy-related registers and from PharmXplorer, a marketing research database from Proxima Research LLC, were used for research. Sales were assessed in terms of both packages and Ukrainian hryvnias (₴). Retrospective, structural and graphical methods were used for research. Results: Of the TRPs available on the market, only 10.7% were Ukrainian products. Almost half (46.43%) of the TRPs were those whose price range was from ₴101 to ₴200. The smallest share of the market (14.28%) was attributed to the most expensive TRPs. In addition, almost half of the products of the lowest price range (₴100 and under) were domestic products. Conclusion: the number of domestic TRPs in the Ukrainian pharmaceutical market is limited. A stable increase in TRP retail sales both in packages and hryvnias indicates a stable and positive increase in demand for therapeutic products for dry eye patients. A Ukrainian lowest-price niche medical device containing both dexpanthenol and taurin was an absolute leader of 2016-2019 TRP retail sales.